Back to All

Dr. Molly Davis, MD

She / Her / Hers
Co-founder, Psychiatrist

I received my B.S. in Human Biology from Stanford University. I graduated from the University of Washington School of Medicine in 2001 and completed a general psychiatry residency and geriatric psychiatry fellowship at Oregon Health & Science University. I served as chief resident in my final year of training. I am board certified in both general and geriatric psychiatry.

Following my training, I joined the faculty at OHSU as a geriatric psychiatrist, specializing in treating patients with refractory mood disorders with electroconvulsive therapy, evaluating and treating patients with major neurocognitive disorders (dementia), and evaluating and treating patients with movement disorders. I have additional training in general neurology and movement disorders. Subsequently, I worked in various inpatient and outpatient psychiatric settings. Since 2015, my focus has been on using deep transcranial magnetic stimulation (dTMS) for treatment-resistant mental illness.

I am thrilled to be partnering with Dr. Eliza Brink, DNP, PMHNP-BC, at Clear Path Psychiatry, an innovative interventional psychiatry practice in Seattle, Washington. We are proud to offer dTMS to treat treatment-resistant depression and obsessive-compulsive disorder, using the Brainsway H1 and H7 coils. We also offer Spravato (intranasal esketamine) as an augmenting agent for patients suffering from depression or depression with suicidal thoughts or actions.

In 2018, I immersed myself in studying psychedelic medicine. Trained through the Multidisciplinary Association for Psychedelic Studies (MAPS) to offer MDMA-assisted therapy for individuals with treatment-resistant PTSD pending FDA-approval. I am currently undergoing a year-long fellowship through the Integrative Psychiatry Institute in psychedelic-assisted therapy and am eager to offer psychedelic and entheogenic medicines as they gain FDA-approval.

Beyond my professional pursuits, my personal journey has equipped me with a unique perspective on navigating life as a patient. Having undergone treatment for triple-negative breast cancer in 2018, followed by acute myeloid leukemia and a stem-cell (bone marrow) transplant in 2020, I have a profound understanding of the challenges faced by individuals with life-threatening illnesses and those confronting mortality. I know how challenging it is to navigate the medical system. I like to work closely with patients to guide them through interventional psychiatric treatments on a path to mental health and well-being. I am passionate about working with people who live with life-threatening and chronic illnesses. I believe that psychedelic-assisted therapy can help individuals find meaning, hope, and joy in their lives, even when facing mortality.

Areas of Focus

Depression, Anxiety, OCD, and PTSD. Does not provide medication management.